SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-000265
Filing Date
2020-01-06
Accepted
2020-01-06 16:26:23
Documents
3
Period of Report
2019-12-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k123019_bioxytraninc.htm 8-K 29580
2 SECURITIES PURCHASE AGREEMENT BETWEEN POWER UP LENDING GROUP AND BIOXYTRAN, INC. f8k123019ex10-42_bioxytran.htm EX-10.42 78553
3 8% CONVERTIBLE NOTE OF BIOXYTRAN, INC. TO POWER UP LENDING GROUP IN THE PRINCIPA f8k123019ex10-43_bioxytran.htm EX-10.43 111481
  Complete submission text file 0001213900-20-000265.txt   221152
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 20510052
SIC: 2834 Pharmaceutical Preparations